Sareum business model24 Oct 2023 18:51
The strategy outlined by the BOD is beginning to concern me. We have 2 clinical stage drugs and 1 preclinical, you would have thought that some kind of activity promoting these drugs would be in the public domain. In addition to this, it is also disappointing that the CPF/Sixth Element Captial are doing sweet fa with 737, just have a look at their website for an example. While I have faith in the science, I am not happy with the overall business acumen.